Here, we examine whether RA190 inhibits the NF-κB pathway by preventing IκBα degradation by the proteasome, causing the cytoplasmic accumulation of NF-κB in HCC cells. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.